Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

603 ARTÍCULOS , VIENDO DEL 361 AL 375

New insights into the pathogenesis and therapeutics of episodic ataxia type 1

D'Adamo MC, Hasan S, Guglielmi L, Servettini I, Cenciarini M, Catacuzzeno L, Franciolini F.

Front Cell Neurosci. 2015 Aug 19;9:317. doi: 10.3389/fncel.2015.00317. eCollection 2015.

T-CELL LYMPHOCYTIC LEUKEMIA IN A FALLOW DEER (DAMA DAMA)

Suedmeyer WK, Stockinger BG, Garner MM, Bradway DS, Hollinger C, Kiupel M.

J Zoo Wildl Med. 2015 Sep;46(3):580-2. doi: 10.1638/2014-0207.1.

Visual symptoms in the presentation of Creutzfeldt-Jakob disease

Wong A, Matheos K, Danesh-Meyer HV.

J Clin Neurosci. 2015 Oct;22(10):1688-9. doi: 10.1016/j.jocn.2015.05.006.

Efficacy of Rituximab in Refractory Cold Agglutinin Hemolytic Anemia in a Patient with Ataxia-Telangiectasia

Abdulhag UN, Liebster D, Eisenstein EM, Berkun Y.

Isr Med Assoc J. 2015 Jul;17(7):455-6.

A Comparative Meta-Analysis of Tick Paralysis in the United States and Australia

Diaz JH.

Clin Toxicol (Phila). 2015 Nov;53(9):874-83. doi: 10.3109/15563650.2015.1085999. Epub 2015 Sep 11.

Structural studies of parkin and sacsin: Mitochondrial dynamics in neurodegenerative diseases

Li X, Gehring K.

Mov Disord. 2015 Oct;30(12):1610-9. doi: 10.1002/mds.26357. Epub 2015 Sep 11.

[A Case of Sporadic Creutzfeldt-Jakob Disease That Developed With Psychiatric Symptoms]

Özkan A, Aydın Cantürk İ, Candan F, Işık N, Özışık Karaman HI.

Turk Psikiyatri Derg. 2015 Fall;26(3):213-6.

A misdiagnosed myasthenia gravis with anti-muscle-specific tyrosine kinase antibodies with possible childhood onset

Nikolić AV, Lavrnić DV, Basta IZ, Nikolić DM, Apostolski SA.

Vojnosanit Pregl. 2015 Jul;72(7):639-41. doi: 10.2298/vsp131111039n.

Advances in the Understanding of the Gabaergic Neurobiology of FMR1 Expanded Alleles Leading to Targeted Treatments for Fragile X Spectrum Disorder

Lozano R, Martinez-Cerdeno V, Hagerman RJ.

Curr Pharm Des. 2015;21(34):4972-4979. doi: 10.2174/1381612821666150914121038.

GABAergic Pharmacotherapy in the Treatment of Motor Disorders of the Central Nervous System

Gazulla J, Ruiz-Gazulla C, Tintore M.

Curr Pharm Des. 2015;21(34):4989-95. doi: 10.2174/1381612821666150914120923.

Fragile X-Associated Tremor/Ataxia Syndrome in a Man in His 30s

Martínez-Cerdeño V, Lechpammer M, Lott A, Schneider A, Hagerman R.

JAMA Neurol. 2015 Sep;72(9):1070-3. doi: 10.1001/jamaneurol.2015.1138.

[Clinical characteristics of four patients with temporal lobe epilepsy associated with elevated anti-GAD antibodies]

Akaishi T, Jin K, Kato K, Itabashi H, Misu T, Tateyama M, Iwasaki M, Aoki M, Nakasato N.

Rinsho Shinkeigaku. 2015;55(11):804-9. doi: 10.5692/clinicalneurol.cn-000740. Epub 2015 Sep 11.

Analysis of SCA8, SCA10, SCA12, SCA17 and SCA19 in patients with unknown spinocerebellar ataxia: a Thai multicentre study

Choubtum L, Witoonpanich P, Hanchaiphiboolkul S, Bhidayasiri R, Jitkritsadakul O, Pongpakdee S, Wetchaphanphesat S, Boonkongchuen P, Pulkes T.

BMC Neurol. 2015 Sep 15;15:166. doi: 10.1186/s12883-015-0425-y.

Varicella Zoster Virus Cerebellitis Without a Rash in an Immunocompetent 85-Year-Old Patient

Shilo S, Wiener-Well Y, Korn-Lubetzki I.

Neurologist. 2015 Sep;20(3):44-5. doi: 10.1097/NRL.0000000000000051.

Friedreich Ataxia: From the Eye of a Molecular Biologist

Muthuswamy S, Agarwal S.

Neurologist. 2015 Sep;20(3):51-5. doi: 10.1097/NRL.0000000000000054.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias